基本信息
views: 32

Bio
The Biochemistry of Diabetes Complications Laboratory addresses important mechanistic questions across the spectrum of diabetic complications. This work is directed towards the development of novel preventive, diagnostic and therapeutic strategies through multidisciplinary approaches combining bench-top research with human physiology and clinical studies. Our work directly impacts on patient care and has been published in major journals including Circulation Research, Diabetes, Diabetes Care and Diabetologia.
Professor Merlin Thomas is an internationally recognised clinician-scientist working in the field of diabetic complications, an area of utmost importance for the health of Australians. He is trained in both nephrology and endocrinology, but is also a state-of-the-art molecular scientist. Globally, he is the third-highest ranked expert in diabetic kidney disease and recognised as an opinion leader in the field of diabetic complications. His translational research spans basic biochemistry and biology to epidemiology and clinical trials. Dr Thomas has an exceptional track record of productivity with more than 270 publications many in the highest ranked journals in his field. He is also a sought-after speaker, teacher and best-selling author, demonstrating his exceptional capability to communicate complex scientific understanding to a general audience.
As both a clinician and a scientist, Professor Thomas’ work is keenly focused on the application of his work, improving the understanding and management of diabetic complications. This work has led to the establishment of international patents as well as influencing national and international guidelines. He is CIB in the newly created NHMRC Diabetes Complications CRE. His “Biochemistry of Diabetes Complications” laboratory in the newly created Department of Diabetes at Monash University is an ideal environment for multidisciplinary research, providing a combination of intellectual and scientific expertise, high-quality infrastructure and state-of-the-art capabilities.
The principal objective of Professor Thomas' research laboratory is to advance the field of diabetes by identifying and validating novel targets towards the development of efficacious strategies for the prevention and management of diabetic complications.
Professor Merlin Thomas is an internationally recognised clinician-scientist working in the field of diabetic complications, an area of utmost importance for the health of Australians. He is trained in both nephrology and endocrinology, but is also a state-of-the-art molecular scientist. Globally, he is the third-highest ranked expert in diabetic kidney disease and recognised as an opinion leader in the field of diabetic complications. His translational research spans basic biochemistry and biology to epidemiology and clinical trials. Dr Thomas has an exceptional track record of productivity with more than 270 publications many in the highest ranked journals in his field. He is also a sought-after speaker, teacher and best-selling author, demonstrating his exceptional capability to communicate complex scientific understanding to a general audience.
As both a clinician and a scientist, Professor Thomas’ work is keenly focused on the application of his work, improving the understanding and management of diabetic complications. This work has led to the establishment of international patents as well as influencing national and international guidelines. He is CIB in the newly created NHMRC Diabetes Complications CRE. His “Biochemistry of Diabetes Complications” laboratory in the newly created Department of Diabetes at Monash University is an ideal environment for multidisciplinary research, providing a combination of intellectual and scientific expertise, high-quality infrastructure and state-of-the-art capabilities.
The principal objective of Professor Thomas' research laboratory is to advance the field of diabetes by identifying and validating novel targets towards the development of efficacious strategies for the prevention and management of diabetic complications.
Research Interests
Papers共 436 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Gary Anderson, Aowen Zhuang, Rachael Hu,Philip Hansbro, Christopher Wraight,Raelene Pickering,Merlin Thomas
Airway pharmacology and treatment (2024)
NATURE REVIEWS NEPHROLOGYno. 10 (2024): 637-638
KIDNEY MEDICINEno. 3 (2024)
Management of Chronic Kidney Diseasepp.123-134, (2023)
Ishant Khurana,Harikrishnan Kaipananickal,Scott Maxwell,Sorine Birkelund,Anna Syreeni,Carol Forsblom,Jun Okabe,Mark Ziemann,Antony Kaspi,Haloom Rafehi,Anne Jorgensen,Keith Al-Hasani,Merlin C. Thomas,Guozhi Jiang,Andrea O. Y. Luk,Heung Man Lee,Yu Huang,Yotsapon Thewjitcharoen,Soontaree Nakasatien,Thep Himathongkam,Christopher Fogarty,Rachel Njeim,Assaad Eid,Tine Willum Hansen,Nete Tofte,Evy C. Ottesen,Ronald C. W. Ma,Juliana C. N. Chan,Mark E. Cooper,Peter Rossing,Per-Henrik Groop,Assam El-Osta
Stefanie M. Bader,James P. Cooney,Dylan Sheerin,George Taiaroa,Leigh Harty,Kathryn C. Davidson,Liana Mackiewicz,Merle Dayton,Stephen Wilcox,Lachlan Whitehead,Kelly L. Rogers,Smitha Rose Georgy,Anna K. Coussens,Samantha L. Grimley, Vincent Corbin,Miranda Pitt,Lachlan Coin,Raelene Pickering,Merlin Thomas,Cody C. Allison,Julie McAuley,Damian F. J. Purcell,Marcel Doerflinger,Marc Pellegrini
Load More
Author Statistics
#Papers: 436
#Citation: 21435
H-Index: 77
G-Index: 135
Sociability: 7
Diversity: 4
Activity: 35
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn